The powerhouse CEOs of the midwest
Also: Bessent calls tariff uncertainty “strategic” and Biden diagnosed with prostate cancer.
Fortune
•
2 hours ago
Stiff competition and a shift in demand towards entry-tier smartphones pushed Qorvo shares down about 38% last year. In April, Starboard said it delivered a letter to Qorvo, nominating Feld for election to the board and increased its stake in the company to about 8.9%.
The powerhouse CEOs of the midwest
Also: Bessent calls tariff uncertainty “strategic” and Biden diagnosed with prostate cancer.
Fortune
•
2 hours ago

Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news

Loop Capital sees shares of Qualcomm surging 32% from here.

The RV manufacturer believes the stock price doesn't fully reflect the Fortune 500 company's true value.

The move raises privacy concerns as the drugmaker takes control of the genetic data of millions of clients of the once-sizzling…

Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout